SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125413
Filing Date
2024-11-12
Accepted
2024-11-12 16:14:15
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20240930.htm   iXBRL 10-Q 1703179
2 EX-31.1 bolt-ex31_1.htm EX-31.1 13214
3 EX-32.1 bolt-ex32_1.htm EX-32.1 6812
  Complete submission text file 0000950170-24-125413.txt   7168683

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240930.xsd EX-101.SCH 923208
61 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240930_htm.xml XML 1375923
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 241448312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)